David A. Socks

Insider Reports History

Entity
Individual
Location
C/O Cadence Pharmaceuticals, Inc., 12481 High Bluff Drive, Suite 200, San Diego, CA
Signature
/s/ Molly Henderson, Attorney-in-Fact for David A. Socks
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David A. Socks:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HilleVax, Inc. CFO & Chief Business Officer Common Stock 769K $11.9M $15.50 Apr 28, 2022 Indirect
Phathom Pharmaceuticals, Inc. Director Common Stock 1.21M $11M $9.11 May 23, 2024 David A. Socks Family Trust
Phathom Pharmaceuticals, Inc. Director Common Stock 19.5K $178K $9.11 May 23, 2024 Direct
Phathom Pharmaceuticals, Inc. Director Common Stock 410 $3.73K $9.11 May 23, 2024 By 401(k)
Phathom Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 17.5K May 23, 2024 Direct

Insider Reports Filed by David A. Socks

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PHAT Phathom Pharmaceuticals, Inc. May 23, 2024 2 $0 4 May 24, 2024 Director
PHAT Phathom Pharmaceuticals, Inc. May 25, 2023 2 $0 4 May 30, 2023 Director
PHAT Phathom Pharmaceuticals, Inc. May 25, 2022 1 $0 4 May 27, 2022 Director
HLVX HilleVax, Inc. Apr 28, 2022 0 $0 3 Apr 28, 2022 CFO & Chief Business Officer
PHAT Phathom Pharmaceuticals, Inc. Oct 7, 2021 2 -$586K 4 Oct 8, 2021 Director
PHAT Phathom Pharmaceuticals, Inc. Sep 21, 2021 3 -$587K 4 Sep 23, 2021 Director
PHAT Phathom Pharmaceuticals, Inc. Aug 16, 2021 2 -$563K 4 Aug 18, 2021 Director
PHAT Phathom Pharmaceuticals, Inc. Jun 28, 2021 3 -$1.36M 4 Jun 29, 2021 Director
PHAT Phathom Pharmaceuticals, Inc. May 21, 2021 1 $0 4 May 24, 2021 Director
PHAT Phathom Pharmaceuticals, Inc. May 19, 2021 6 -$1.31M 4 May 21, 2021 Director